NEW YORK (GenomeWeb News) – Siemens Healthcare Diagnostics will provide the Mayo Clinic with two of its molecular testing products for use in screening for major diseases, Siemens said today.

Under the five-year agreement, the Mayo Clinic will use Siemens’ Versant and Trugene products to assess human immunodeficiency virus, hepatitis B and hepatitis C viral load, genotyping, and drug resistance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.